HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?

Impact · against what's priced in

HealthEquity's strong Q2 results and raised fiscal 2027 guidance provide positive momentum, though legal and regulatory headwinds limit the upside. The growth in HSA investment assets and expanded margins signal operational efficiency and successful scaling.

HQY+0.40

No priced-in read yet

In context

The company raised fiscal 2027 revenue guidance to $1.411-$1.421 billion and adjusted EBITDA to $628-$636 million, supported by a 220 basis point gross margin expansion to 73.5%.

Read from the article alone

• earnings▲26%
• guidance▲8%
• healthcare
• HQY
• cybersecurity
• hsa
• interest rates
• regulation